Johnson & Johnson | Vision

As J&J MedTech, a leader in eye health, we are paving the way for a new future of vision care at every stage of life.

General Information
Company Name
Johnson & Johnson | Vision
Founded Year
2005
Location (Offices)
Jacksonville, United States +1
Founders / Decision Makers
Number of Employees
5509
Industries
Health Care, Medical Devices
Funding Stage
Series D
Social Media

Johnson & Johnson | Vision - Company Profile

LIPIFLOW is a pioneering medical device company in the Biotechnology and Health Care industries. Founded in 2005 and headquartered in the United States, the company focuses on improving the evaluation and treatment of meibomian gland dysfunction (MGD), which is the root cause of dry eye and affects approximately 86% of the 300 million dry eye sufferers worldwide. Their innovative technologies, including LipiView II and new LipiScan with Dynamic Meibomian Imaging™ (DMI), allow for distinctive imaging of meibomian gland structure. Additionally, the Korb Meibomian Gland Evaluator™ assists physicians in assessing gland function, while LipiFlow utilizes Vectored Thermal Pulse™ (VTP) technology to precisely direct treatment, receiving clearance by the US Food and Drug Administration.

The company secured a noteworthy $19.23M Series D investment on 14 April 2016, with funding from prominent investors such as EW Healthcare Partners, General Catalyst, Investor Growth Capital, De Novo Ventures, and HealthCare Royalty Partners. Sponsored and unsponsored multicenter, randomized, controlled clinical studies of LipiFlow consistently showcased its safety and sustained effectiveness, highlighting its potential in addressing a prevalent healthcare issue.

LIPIFLOW's commitment to advancing the evaluation of MGD and improving the quality of life for patients with this condition underscores its potential for growth and impact within the healthcare industry.

Taxonomy: Meibomian Gland Dysfunction, Dry Eye, Ophthalmic Solutions, Optometric, Tear Film, Eye Care, LipiFlow, Healthcare Innovation, Meibomian Gland Evaluation, Medical Technology, Clinical Studies, Eye Health, Meibomian Gland Imaging, MGD Treatment

Funding Rounds & Investors of Johnson & Johnson | Vision (0)

View All

There is no investment information

Latest News of Johnson & Johnson | Vision

View All

No recent news or press coverage available for Johnson & Johnson | Vision.

Similar Companies to Johnson & Johnson | Vision

View All
Novaliq GmbH - Similar company to Johnson & Johnson | Vision
Novaliq GmbH Transforming Ocular Therapeutics
ThermaMEDx, LLC - Similar company to Johnson & Johnson | Vision
ThermaMEDx, LLC A New Vision in Eyecare Providing Positive Disruption in Optical Medical Devices
Visionix - Similar company to Johnson & Johnson | Vision
Visionix Innovation to unlock your potential
Vold Vision - Similar company to Johnson & Johnson | Vision
Vold Vision Ophthalmology Clinics Located Across NW Arkansas - FDA Research Facility - Joint Commission Certified Surgery Center
JEC Eye Hospitals & Clinics - Similar company to Johnson & Johnson | Vision
JEC Eye Hospitals & Clinics Care With Experience